MCID/Low Disease Activity State Workshop: summary, recommendations, and research agenda.
The OMERACT 6 Minimal Clinically Important Difference/Low Disease Activity Workshop was organized with the aim of meeting the many challenges that exist in determining a low disease activity in rheumatoid arthritis (RA). This article presents an overview of that workshop, including results of the voting, a summary of associated discussions, recommendations, and a proposed research agenda.
Department of Clinical Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada.
George
G
Wells
Jennifer
J
Anderson
Maarten
M
Boers
David
D
Felson
Turid
T
Heiberg
Sarah
S
Hewlett
Kent
K
Johnson
John
J
Kirwan
Marissa
M
Lassere
Vivian
V
Robinson
Beverley
B
Shea
Lee
L
Simon
Vibeke
V
Strand
Piet
P
van Riel
Peter
P
Tugwell
D001172:Arthritis, Rheumatoid / Q000175:diagnosis* / Q000503:physiopathology* / Q000628:therapy; D006801:Humans; D010043:Outcome and Process Assessment, Health Care; D012720:Severity of Illness Index